Anika Therapeutics ANIK Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's short-term investments?
- Anika Therapeutics (ANIK) reported short-term investments of $25.77M in Q1 2026.
- How has Anika Therapeutics's short-term investments changed year-over-year?
- Anika Therapeutics's short-term investments increased by 17.2% year-over-year, from $21.99M to $25.77M.
- What is the long-term trend for Anika Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Anika Therapeutics's short-term investments has grown at a 56.8% compound annual growth rate (CAGR), from $2.5M to $23.69M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.